Fulgent Genetics Inc (FLGT) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $24.76
• Market Cap: $728.30M
• EPS: $-1.40
• 52-Week High: $31.04
• 52-Week Low: $14.57

Market Sentiment

Fulgent Genetics Inc currently has a Neutral sentiment score of -0.09.

About Fulgent Genetics Inc

Fulgent Genetics, Inc. is a leading provider of advanced genetic testing and diagnostic solutions, headquartered in Temple City, California. The company utilizes innovative technology to offer a wide range of testing services, including comprehensive genomics and COVID-19 diagnostics, aimed at delivering clinically actionable insights for healthcare providers. Fulgent's commitment to precision and innovation positions it as a key player in the rapidly advancing fields of genetic medicine and ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Fulgent Genetics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FLGT pay dividends?

Fulgent Genetics Inc (FLGT) does not currently pay a regular dividend.

What is FLGT's market cap?

Fulgent Genetics Inc (FLGT) has a market capitalization of $728.30M with a current stock price of $24.76.